Related Experiment Videos
Cytological analysis of radiation-induced DNA amplification in C57BL/6 mice
1Institute of Biology, Research Centre Seibersdorf, Austria.
Abstract:
Inbred mouse strain C57BL/6 pre-treated with or without the drug with suspected anticancer activity, DADH (N, N'-Diacetyl-1, 6-Diaminohexane) by daily feeding for five consecutive days to a total dose of 1 mmol of the drug in aqueous solution, were exposed to an acute dose of 1 Gy gamma radiation. Appropriate controls without radiation were maintained both for water and DADH-fed groups of animals. At 18 and 36 h post-irradiation the animals from all four groups (designated as A to D with each group having six animals) were sacrificed and their bone marrows were cultured for chromosomal analysis. Special emphasis was put on the estimation of the frequency of occurrence of extra chromosomal elements, such as minutes, single or double (DMS) as a possible assay for radiation-induced DNA amplification (presumably representing the proliferation specified genes(?) causing initiation of a very early tumourigenesis event). Gamma irradiation alone yielded the highest frequency of such minute chromosomal structures concerned (DMS), which was significantly reduced by DADH pre-treatment. The preliminary cytological data are discussed in the light of current information on DNA amplification pertaining to carcinogenic induction.
Insights
Pre-treatment with DADH (N, N'-Diacetyl-1, 6-Diaminohexane) significantly reduced radiation-induced DNA amplification, indicated by fewer minute chromosomal structures (DMS), in mouse bone marrow.
Area of Science:
- Radiobiology
- Genetics
- Pharmacology
Background:
- Gamma radiation exposure can induce DNA amplification, a potential early event in carcinogenesis.
- Extra-chromosomal elements like double minutes (DMS) are indicators of DNA amplification.
- DADH (N, N'-Diacetyl-1, 6-Diaminohexane) is a drug with suspected anticancer activity.
Purpose of the Study:
- To investigate the effect of DADH pre-treatment on gamma radiation-induced DNA amplification.
- To assess the potential of DADH as a radioprotective agent against DNA damage.
Main Methods:
- Inbred C57BL/6 mice were pre-treated with DADH or vehicle.
- Mice were exposed to a single dose of 1 Gy gamma radiation.
- Bone marrow chromosomal analysis was performed 18 and 36 hours post-irradiation.
- Frequency of double minutes (DMS) was quantified as a marker for DNA amplification.
Main Results:
- Gamma irradiation alone significantly increased the frequency of DMS.
- DADH pre-treatment markedly reduced the occurrence of DMS in irradiated mice.
- A control group without radiation showed minimal DMS presence.
Conclusions:
- DADH exhibits radioprotective properties by mitigating radiation-induced DNA amplification.
- DADH may hold potential for cancer prevention or treatment strategies involving radiation exposure.
- Further research is warranted to elucidate the mechanisms of DADH's radioprotective effects.